Do NOT Give FFP to This Patient
In a volume-overloaded patient with rhabdomyolysis-induced acute kidney injury and deranged PT/INR who is not actively bleeding, FFP transfusion is contraindicated and should be avoided. 1, 2, 1
Why FFP Should Be Withheld
Volume Overload is a Critical Contraindication
The patient's existing volume overload makes FFP particularly dangerous. Each unit of FFP contains approximately 250-300 mL of fluid 3. In a volume-overloaded patient, this additional fluid burden can precipitate:
- Transfusion-associated circulatory overload (TACO) - a potentially fatal complication 4
- Worsening pulmonary edema
- Increased portal pressure (if liver dysfunction present) 5
- Acute respiratory distress syndrome 6
A case report 4 directly illustrates this danger: a volume-overloaded patient with elevated INR received 4 units of FFP to correct INR from 3.0 to 1.5 before a procedure. The INR only decreased to 1.9, and the patient developed acute pulmonary edema and died within 24 hours.
FFP Does Not Correct Non-Bleeding Coagulopathy
Multiple high-quality guidelines explicitly recommend against FFP use in non-bleeding patients with deranged coagulation tests:
2025 Association of Anaesthetists Guidelines: "There is no good evidence to support the use of prophylactic FFP to correct abnormal coagulation tests prior to low-risk invasive procedures in patients who are critically ill" 1
2017 Surviving Sepsis Campaign: "We suggest against the use of fresh frozen plasma to correct clotting abnormalities in the absence of bleeding or planned invasive procedures (weak recommendation, very low quality of evidence)" 2
2025 CHEST Guidelines: Recommend against routine prophylactic FFP transfusion in critically ill patients with coagulopathy undergoing most procedures 7
FFP is Ineffective at Correcting Mild-Moderate INR Elevation
Research demonstrates FFP's futility in this scenario:
A 2015 study 8 of 38 critically ill patients with INR 1.5-3.0 showed FFP transfusion (12 mL/kg) failed to induce a more procoagulant state despite increasing individual factor levels
A 2006 prospective audit 9 found FFP normalized PT-INR in only 0.8% of patients with mild coagulopathy (INR 1.1-1.85), and failed to correct PT in 99% of patients
A 2026 study 10 showed FFP achieved INR normalization in only 7.9% of patients with infection-associated coagulopathy, with significant delays in necessary procedures
The Coagulopathy is Secondary to Rhabdomyolysis
The deranged PT/INR in rhabdomyolysis represents:
- Hepatic dysfunction from muscle breakdown products, hyperpyrexia, and hypotension 11
- A reversible abnormality that resolves with treatment of the underlying condition 11
- Part of a "rebalanced hemostasis" where both procoagulant and anticoagulant factors are affected 1, 3, 1
The 1990 study 11 documented that hepatic dysfunction occurs in ~25% of rhabdomyolysis patients, with prolonged PT in 33-63% of cases, but these abnormalities are reversible and resolve spontaneously.
What TO Do Instead
1. Treat the Underlying Rhabdomyolysis
- Aggressive fluid resuscitation (when volume status permits) 12
- Manage electrolyte abnormalities (hyperkalemia, hyperphosphatemia, hypocalcemia) 12
- Consider kidney replacement therapy if indicated 12
- Address the volume overload with diuretics or ultrafiltration
2. Monitor for Active Bleeding
FFP is only indicated if the patient develops:
- Active bleeding with INR >2.0 or PT >1.5 times normal 13
- Excessive microvascular bleeding (coagulopathy) 13
3. If Invasive Procedures Are Needed
For most procedures, prophylactic FFP is NOT needed:
- Central lines, arterial lines: No FFP needed 7
- Paracentesis, thoracentesis: No FFP needed 5, 3
- Most bedside procedures: No FFP needed 1
Only consider FFP for high-risk procedures:
- Lumbar puncture: Target INR 1.5-2.0 7
- Neurosurgical procedures: May require correction
- Procedures where bleeding would be catastrophic
4. Alternative Strategies if Correction Absolutely Required
- Prothrombin complex concentrate (PCC): Minimal volume (10-20 mL), more effective than FFP 5
- Vitamin K: 10 mg IV/PO if nutritional deficiency or malabsorption suspected 5
- Address volume overload first before considering any blood products
Critical Pitfalls to Avoid
Do not transfuse FFP "just because the INR is high" - this is the most common inappropriate indication 1, 5, 1
Do not assume elevated INR = bleeding risk in non-bleeding critically ill patients - standard coagulation tests are poor predictors 1
Do not ignore volume status - TACO can be fatal 4
Do not delay necessary procedures waiting for INR correction - a 2026 study 10 showed median 9-hour delay in lifesaving drainage procedures due to futile FFP transfusion attempts
Do not use FFP for volume replacement - this is explicitly contraindicated 13, 1, 3, 13, 1